The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide

References

• World Health OrganizationGlobal Tuberculosis Report 2015GenevaWorld Health Organization2015
   Google Scholar
• GavazziGHerrmannFKrauseKHAging and infectious diseases in the developing worldClin Infect Dis2004391839115206058
   PubMed Web of Science ®Google Scholar
• KinsellaKPhillipsDRGlobal aging: the challenge of successPopul Bull2005601142
   Google Scholar
• Ministry of the Interior Republic of China (Taiwan)Statistical Yearbook of InteriorTaiwanMinistry of the Interior, Republic of China (Taiwan)2014
   Google Scholar
• RajagopalanSTuberculosis and aging: a global health problemClin Infect Dis20013371034103911528577
   PubMed Web of Science ®Google Scholar
• LeungCCYewWWChanCKTuberculosis in older people: a retrospective and comparative study from Hong KongJ Am Geriatr Soc20025071219122612133016
   PubMed Web of Science ®Google Scholar
• ZecallosMJustmanJETuberculosis in the elderlyClin Geriatr Med20031912113812735118
   PubMed Web of Science ®Google Scholar
• LeeJHHanDHSongJWChungHSDiagnostic and therapeutic problems of pulmonary tuberculosis in elderly patientsJ Korean Med Sci20052078478916224152
   PubMed Web of Science ®Google Scholar
• TowhidiMAzarianAAsnaashariAPulmonary tuberculosis in the elderlyTanaffos2008715257
   Google Scholar
• PackhamSTuberculosis in the elderlyGerontology200147417517911408720
   PubMed Web of Science ®Google Scholar
• RizviNShahRHInayatNHussainNDifferences in clinical presentation of pulmonary tuberculosis in association with ageJ Pak Med Assoc200353832132414558733
   PubMedGoogle Scholar
• SalvadóMGarcia-VidalCVázquezPMortality of tuberculosis in very old peopleJ Am Geriatr Soc2010581182220122037
   PubMed Web of Science ®Google Scholar
• LinYSYenYFDeterminants of mortality before start of and during tuberculosis treatment among elderly patients: a population-based retrospective cohort studyAge Ageing201544349049625670782
   PubMed Web of Science ®Google Scholar
• Philadelphia Tuberculosis Control ProgramGuidelines for the Management of Adverse Drug Effects of Antimycobacterial Agents Lawrence Flick Memorial Tuberculosis ClinicPhiladelphiaPhiladelphia Tuberculosis Control Program1998
   Google Scholar
• ChangFYChouJHChuangJHTaiwan Tuberculosis Report 2013TaiwanCenters for Disease Control, Ministry of Health and Welfare, R. O. C. (Taiwan)2014
   Google Scholar
• British Thoracic Society (BTS)Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint tuberculosis committed of the British Thoracic SocietyThorax1998535365489797751
   PubMed Web of Science ®Google Scholar
• SaukkonenJJCohnDLJasmerRMATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy SubcommitteeAn official ATS statement: hepatotoxicity of antituberculosis therapyAm J Respir Crit Care Med2006174893595217021358
   PubMed Web of Science ®Google Scholar
• BaghaeiPTabarsiPChitsazEIncidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to anti-tuberculosis agents in new tuberculosis casesAm J Ther2010171172219535968
   PubMed Web of Science ®Google Scholar
• GaudeGSChaudhuryAHattiholiJDrug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patientsJ Family Med Prim Care20154223824325949974
   PubMedGoogle Scholar
• HosfordJDvon FrickenMELauzardoMHepatotoxicity from antituberculous therapy in the elderly: a systematic reviewTuberculosis (Edinb)201595211212225595441
   PubMed Web of Science ®Google Scholar
• MakhloufHAHelmyAFawzyEEl-AttarMRashedHAA prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseaseHepatol Int20082335336019669265
   PubMed Web of Science ®Google Scholar
• BakerMAHarriesADJeonCYThe impact of diabetes on tuberculosis treatment outcomes: a systematic reviewBMJ Med2011981
   Google Scholar
• WangZHallSDMayaJFLiLAsgharAGorskiJCDiabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humansBr J Clin Pharmacol2003551778512534643
   PubMed Web of Science ®Google Scholar
• WangTYuHTWangWPanYYHeLXWangZYGenetic polymorphisms of cytochrome p450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patientsJ Int Med Res201038397798620819434
   PubMed Web of Science ®Google Scholar
• LianYZhaoJXuPProtective effects of metallothionein on isoniazide and rifampicin-induced hepatotoxicity in micePLoS One201388e7205823967274
   PubMed Web of Science ®Google Scholar
• HwangSJWuJCLeeCNA prospective clinical study of isonizide-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis BJ Gastroenterol Hepatol19971287919076631
   PubMed Web of Science ®Google Scholar
• LeeBHKohWJChoiMSInactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapyChest20051271304131115821209
   PubMed Web of Science ®Google Scholar
• WongWMWuPCYuenMFAntituberculosis drug-related liver dysfunction in chronic hepatitis B infectionHepatology20003120120610613746
   PubMed Web of Science ®Google Scholar
• ChienJYHuangRMWangJYHepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatmentInt J Tuberc Lung Dis201014561662120392356
   PubMed Web of Science ®Google Scholar
• KwonYSKohWJSuhGYChungMPKimHKwonOJHepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapyChest2007131380380817356096
   PubMed Web of Science ®Google Scholar
• LiuYMChengYJLiYLLiuCEHsuWHAntituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitisLung2014192120521024292367
   PubMed Web of Science ®Google Scholar
• RiederHLKellyGDBlochABCauthenGMSniderDEJrTuberculosis diagnosed at death in the United StatesChest19911006786811889256
   PubMed Web of Science ®Google Scholar
• Pérez-GuzmánCVargasMHTorres-CruzADoes aging modify pulmonary tuberculosis? a meta-analytical reviewChest199911696196710531160
   PubMed Web of Science ®Google Scholar
• García-RodríguezJFÁlvarez-DíazHLorenzo-GarcíaMVMariño-CallejoAFernández-RialÁSesma-SánchezPExtrapulmonary tuberculosis: epidemiology and risk factorsEnferm Infecc Microbiol Clin201129750250921570159
   PubMed Web of Science ®Google Scholar